Attenuated Acceleration to Leukemia after Ezh2 Loss in Nup98-HoxD13 (NHD13) Myelodysplastic Syndrome.


Journal

HemaSphere
ISSN: 2572-9241
Titre abrégé: Hemasphere
Pays: United States
ID NLM: 101740619

Informations de publication

Date de publication:
08 2019
Historique:
received: 07 03 2019
revised: 10 05 2019
accepted: 31 05 2019
entrez: 15 11 2019
pubmed: 15 11 2019
medline: 15 11 2019
Statut: epublish

Résumé

Supplemental Digital Content is available in the text.

Identifiants

pubmed: 31723847
doi: 10.1097/HS9.0000000000000277
pii: HemaSphere-2019-0064
pmc: PMC6745923
doi:

Types de publication

Letter

Langues

eng

Pagination

e277

Informations de copyright

Copyright © 2019 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.

Déclaration de conflit d'intérêts

The authors declare no conflicts of interest.

Références

Blood. 2015 Feb 26;125(9):1367-76
pubmed: 25550361
Lancet. 2014 Jun 28;383(9936):2239-52
pubmed: 24656536
Nat Genet. 2010 Aug;42(8):665-7
pubmed: 20601954
Mol Cell. 2008 Nov 21;32(4):491-502
pubmed: 19026780
N Engl J Med. 2016 Jun 9;374(23):2209-2221
pubmed: 27276561
Genes Dev. 2012 Apr 1;26(7):651-6
pubmed: 22431509
N Engl J Med. 2011 Jun 30;364(26):2496-506
pubmed: 21714648
Blood. 2013 Nov 21;122(22):3616-27; quiz 3699
pubmed: 24030381
Nat Genet. 2010 Aug;42(8):722-6
pubmed: 20601953
Blood. 2012 Feb 2;119(5):1208-13
pubmed: 22053108
Nat Immunol. 2003 Feb;4(2):124-31
pubmed: 12496962
Blood. 2006 Mar 1;107(5):2170-9
pubmed: 16293602
J Exp Med. 2013 Nov 18;210(12):2627-39
pubmed: 24218139
Nature. 2011 Jan 20;469(7330):343-9
pubmed: 21248841
Blood. 2015 Sep 3;126(10):1172-83
pubmed: 26219303
J Clin Oncol. 2012 Sep 20;30(27):3376-82
pubmed: 22869879
Blood. 2011 Dec 15;118(25):6553-61
pubmed: 22042701
Cell Stem Cell. 2014 Jan 2;14(1):68-80
pubmed: 24239285
Blood. 2005 Jul 1;106(1):287-95
pubmed: 15755899
Cell Stem Cell. 2015 Jul 2;17(1):35-46
pubmed: 26095048
Leukemia. 2013 Jun;27(6):1301-9
pubmed: 23486531
Cancer Cell. 2012 Aug 14;22(2):180-93
pubmed: 22897849
Blood. 2011 Dec 8;118(24):6247-57
pubmed: 21948299
Oncotarget. 2016 Feb 16;7(7):8119-30
pubmed: 26812882
Nat Commun. 2014 Jun 23;5:4177
pubmed: 24953053

Auteurs

Victoria Y Ling (VY)

Australian Centre for Blood Diseases, Central Clinical School, Monash University, Melbourne, Australia.
QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Royal Brisbane and Women's Hospital, Brisbane, Australia.

Jesslyn Saw (J)

Australian Centre for Blood Diseases, Central Clinical School, Monash University, Melbourne, Australia.

Cedric S Tremblay (CS)

Australian Centre for Blood Diseases, Central Clinical School, Monash University, Melbourne, Australia.

Stefan E Sonderegger (SE)

Australian Centre for Blood Diseases, Central Clinical School, Monash University, Melbourne, Australia.

Emma Toulmin (E)

Australian Centre for Blood Diseases, Central Clinical School, Monash University, Melbourne, Australia.

Jacqueline Boyle (J)

Australian Centre for Blood Diseases, Central Clinical School, Monash University, Melbourne, Australia.

Sung Kai Chiu (SK)

Australian Centre for Blood Diseases, Central Clinical School, Monash University, Melbourne, Australia.

Steven W Lane (SW)

QIMR Berghofer Medical Research Institute, Brisbane, Australia.
Royal Brisbane and Women's Hospital, Brisbane, Australia.

Stephen B Ting (SB)

Australian Centre for Blood Diseases, Central Clinical School, Monash University, Melbourne, Australia.
Department of Haematology, Eastern Health, Melbourne, Australia.

David J Curtis (DJ)

Australian Centre for Blood Diseases, Central Clinical School, Monash University, Melbourne, Australia.
Department of Clinical Haematology, Alfred Health, Melbourne, Australia.

Classifications MeSH